Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
2.700
-0.160 (-5.59%)
Dec 20, 2024, 4:00 PM EST - Market closed
Skye Bioscience Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$18.67
Upside
+591.48%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Buy Initiates $20 | Buy | Initiates | $20 | +640.74% | Sep 30, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $20 | Buy | Reiterates | $20 | +640.74% | Sep 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +418.52% | Sep 20, 2024 |
| JMP Securities | JMP Securities | Buy Initiates $15 | Buy | Initiates | $15 | +455.56% | Sep 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +418.52% | Sep 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +418.52% | Sep 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +418.52% | Aug 27, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +566.67% | Jul 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +418.52% | Jul 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +418.52% | Jun 18, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +418.52% | Jun 17, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $21 | Buy | Initiates | $21 | +677.78% | May 23, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $25 | Buy | Initiates | $25 | +825.93% | Apr 12, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $12 → $20 | Buy | Reiterates | $12 → $20 | +640.74% | Mar 14, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $12 | Buy | Initiates | $12 | +344.44% | Feb 5, 2024 |